Mdxhealth Sa Adr Stock Today
| MDXH Stock | USD 1.71 0.09 5.56% |
Performance0 of 100
| Odds Of DistressLess than 9
|
MDxHealth is trading at 1.71 as of the 22nd of November 2024. This is a 5.56% increase since the beginning of the trading day. The stock's open price was 1.62. MDxHealth has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for MDxHealth SA ADR are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 28th of November 2023 and ending today, the 22nd of November 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 4th of November 2021 | Category Healthcare | Classification Health Care |
MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, the Netherlands, Belgium, Spain, Poland, Italy, rest of European Union, and internationally. MDxHealth SA was incorporated in 2003 and is headquartered in Herstal, Belgium. The company has 49.5 M outstanding shares of which 14.24 K shares are now shorted by private and institutional investors with about 0.15 trading days to cover. More on MDxHealth SA ADR
Moving together with MDxHealth Stock
| 0.64 | ME | 23Andme Holding | PairCorr |
| 0.9 | VALN | Valneva SE ADR | PairCorr |
| 0.68 | JNJ | Johnson Johnson Sell-off Trend | PairCorr |
Moving against MDxHealth Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
MDxHealth Stock Highlights
| Old Name | Mdxhealth | ||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, Health Care, Biotechnology, Diagnostics & Research, Healthcare (View all Sectors) | ||||
| Average Analyst Recommendation | |||||
Debt LevelsMDxHealth can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand MDxHealth's financial leverage. It provides some insight into what part of MDxHealth's total assets is financed by creditors.
| |||||
MDxHealth SA ADR (MDXH) is traded on NASDAQ Exchange in USA. It is located in CAP Business Center, Herstal, Belgium, 4040 and employs 300 people. MDxHealth is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 84.64 M. MDxHealth SA ADR conducts business under Biotechnology sector and is part of Health Care industry. The entity has 49.5 M outstanding shares of which 14.24 K shares are now shorted by private and institutional investors with about 0.15 trading days to cover.
MDxHealth SA ADR currently holds about 40.02 M in cash with (21.5 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.57, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check MDxHealth Probability Of Bankruptcy
Ownership AllocationMDxHealth SA ADR maintains a total of 49.5 Million outstanding shares. 30% of MDxHealth outstanding shares are owned by institutional investors. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check MDxHealth Ownership Details
MDxHealth Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Rhumbline Advisers | 2024-06-30 | 72.0 |
MDxHealth Historical Income Statement
MDxHealth Stock Against Markets
MDxHealth Corporate Management
| Wim Criekinge | Chief Officer | Profile | |
| Joseph Sollee | Executive Counsel | Profile | |
| Ron CPA | Chief Officer | Profile | |
| John Bellano | Chief Officer | Profile | |
| Jason Poole | Chief Officer | Profile | |
| Miriam Reyes | Executive Operations | Profile | |
| Paul Marr | Ex America | Profile |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MDxHealth SA ADR. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MDxHealth. If investors know MDxHealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MDxHealth listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.53) | Revenue Per Share 3.099 | Quarterly Revenue Growth 0.205 | Return On Assets (0.11) | Return On Equity (2.41) |
The market value of MDxHealth SA ADR is measured differently than its book value, which is the value of MDxHealth that is recorded on the company's balance sheet. Investors also form their own opinion of MDxHealth's value that differs from its market value or its book value, called intrinsic value, which is MDxHealth's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MDxHealth's market value can be influenced by many factors that don't directly affect MDxHealth's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MDxHealth's value and its price as these two are different measures arrived at by different means. Investors typically determine if MDxHealth is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MDxHealth's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.